Here, we are providing promising data in support of challenging breast cancer by targeting thyroid hormone receptors which might provide enough supplementary strength to interfere breast cancer metastasis by adjuvant therapies such as Selective estrogen receptor modulators (SERMs). Here, ESR1 is linked to breast cancer.